Prophylaxis with low dose tranexamic acid in acute myeloid leukemia patients undergoing intensive chemotherapy

Patients suffering from acute myeloid leukemia (AML) carry a high risk of serious bleeding complications due to severe thrombocytopenia for long periods of time during treatment. Prior to prophylactic platelet transfusion becoming the standard of care, intracranial bleeding was a major contributor t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bønløkke, Søren Thorgaard, Severinsen, Marianne Tang, Ommen, Hans Beier, Eriksen, Christian Fenger, Hvas, Anne‐Mette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Haematologic Malignancy ‐ Myeloid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435677/
https://www.ncbi.nlm.nih.gov/pubmed/37601861
http://dx.doi.org/10.1002/jha2.699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435677/
https://www.ncbi.nlm.nih.gov/pubmed/37601861
http://dx.doi.org/10.1002/jha2.699

Ejemplares similares